Candela Laser
This article was originally published in The Gray Sheet
Executive Summary
Expects to report a third quarter loss "on significantly lower revenue," according to an April 5 release. The firm cites "the unsettled outlook for health care reform," lower gross margins and the "continuing impact of absorbing the cost of improvements" to its installed base of PLTL-1 lasers, which are being modified because of "reliability problems." The device is used to remove pigmented lesions and tattoos. For the second quarter ended Jan. 2, the firm reported earnings of $24,000 (down 95.7%) on sales of $9.9 mil. (up 16.5%).